Cohance Lifesciences Ltd header image

Cohance Lifesciences Ltd

543064

Equity

ISIN INE03QK01018 / Valor 46346459

Bombay Stock Exchange Ltd. (Mumbai) (2026-11-06)
INR 433.55-3.59%

Cohance Lifesciences Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Cohance Lifesciences Ltd is an India-based pharmaceutical company that operates as a contract development and manufacturing organization (CDMO), focusing on the development and commercial manufacture of small-molecule active pharmaceutical ingredients (APIs), intermediates and finished dosage forms. The firm provides process development, custom synthesis, scale‑up and commercial production services for domestic and export customers, positioning itself to support pharmaceutical companies through the transition from laboratory-scale chemistry to regulated commercial manufacturing. Its business is driven by contract manufacturing revenue, product sales and development fees, with competitive differentiation depending on technical know‑how, cost‑efficient production and compliance with regulatory quality standards in target markets.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-40.1%1Y
-24.0%3Y
-15.9%5Y

Performance

49.3%1Y
41.7%3Y
36.9%5Y

Volatility

Market cap

1770 M

Market cap (USD)

Daily traded volume (Shares)

83,792

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited Glenmark Pharmaceuticals Limited Valor: 3195888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.32%INR 2,592.85
Alkem Laboratories Ltd.
Alkem Laboratories Ltd. Alkem Laboratories Ltd. Valor: 30689895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.61%INR 5,265.20
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.06%EUR 148.75
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%USD 37.43
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%EUR 77.40
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.93%USD 29.12
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%INR 569.25
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%CHF 8.83
Demant A/S
Demant A/S Demant A/S Valor: 32651962
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.05%DKK 377.20
Piramal Pharma Limited
Piramal Pharma Limited Piramal Pharma Limited Valor: 114197705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.17%INR 239.20